ALLO

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Allogene Therapeutics Inc

NASDAQ | ALLO

1.40

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$328.11M

Market Cap

-

P/E Ratio

-0.98

EPS

$3.78

52 Week High

$0.86

52 Week Low

HEALTHCARE

Sector

ALLO Chart

Recent Chart
Price Action

ALLO Technicals

Tags:

ALLO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $22K
Total Revenue $22K
Cost Of Revenue $14M
Costof Goods And Services Sold $14M
Operating Income -$273M
Selling General And Administrative $65M
Research And Development $192M
Operating Expenses $273M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense $181K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $14M
Income Before Tax -$257M
Income Tax Expense $443K
Interest And Debt Expense -
Net Income From Continuing Operations -$258M
Comprehensive Income Net Of Tax -
Ebit -$257M
Ebitda -$243M
Net Income -$258M

Revenue & Profitability

Earnings Performance

ALLO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $549M
Total Current Assets $303M
Cash And Cash Equivalents At Carrying Value $75M
Cash And Short Term Investments $75M
Inventory -
Current Net Receivables $1.9M
Total Non Current Assets $245M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $81M
Short Term Investments $217M
Other Current Assets $9M
Other Non Current Assets -
Total Liabilities $127M
Total Current Liabilities $36M
Current Accounts Payable $5.4M
Deferred Revenue -
Current Debt -
Short Term Debt $7.5M
Total Non Current Liabilities $91M
Capital Lease Obligations $91M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $91M
Other Current Liabilities $23M
Other Non Current Liabilities $7.8M
Total Shareholder Equity $422M
Treasury Stock -
Retained Earnings -$1.8B
Common Stock $212K
Common Stock Shares Outstanding $195M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$200M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $14M
Capital Expenditures $694K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $76M
Cashflow From Financing $117M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $1.5M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$258M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $22K
Total Revenue $22K
Cost Of Revenue $14M
Costof Goods And Services Sold $14M
Operating Income -$273M
Selling General And Administrative $65M
Research And Development $192M
Operating Expenses $273M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense $181K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $14M
Income Before Tax -$257M
Income Tax Expense $443K
Interest And Debt Expense -
Net Income From Continuing Operations -$258M
Comprehensive Income Net Of Tax -
Ebit -$257M
Ebitda -$243M
Net Income -$258M

ALLO News

ALLO Profile

Allogene Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Allogene Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company based in South San Francisco, California, specializing in the development of next-generation allogeneic T-cell therapies designed to target various forms of cancer. Leveraging its proprietary technology platform, Allogene aims to deliver transformative immuno-oncology treatments that enhance the body’s natural ability to fight cancer while minimizing associated treatment risks and complexities. With a strong pipeline of candidates and a dedicated focus on advancing therapeutic solutions, Allogene is positioned to significantly impact the oncology landscape.

LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
QTTB
+153.42%
$5.54
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
IVP
+7.89%
$0.13
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
BTBT
+2.58%
$2.38
ADTX
+21.01%
$3.80
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CRCL
+10.03%
$79.93
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
CAN
+9.78%
$1.01
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
NWTN
-9.09%
$0.70
AG
+12.73%
$15.23
WBD
+0.50%
$24.00
APLD
+8.66%
$27.10
NGD
+6.50%
$8.35
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
NVDA
-0.38%
$176.31
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.67%
$17.27
ITUB
+1.82%
$7.80
AGNC
+0.47%
$10.49
INTC
-1.89%
$39.79
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
SNAP
-1.43%
$7.56
CRCG
+20.00%
$2.82
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
CRWV
-1.57%
$73.12
SHOT
-74.37%
$0.39
VIVK
-5.32%
$0.12
EXK
+15.19%
$9.93
ZAPP
-46.30%
$0.15
SNDK
+3.83%
$223.28
AVGO
+1.35%
$402.96
CMG
+1.43%
$34.52
MU
+2.70%
$236.48
ABVE
+14.06%
$3.00
NOK
0.00%
$6.08
PLTZ
-3.36%
$7.18
BMNU
-15.39%
$6.92
VSA
-7.30%
$0.11
MRVL
+1.91%
$89.40
SOUN
+1.94%
$12.05
SMCI
+3.10%
$33.85
IONZ
-10.02%
$4.13
IONQ
+5.11%
$49.30
BULL
+0.75%
$9.33
LAES
+6.93%
$4.47
LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
QTTB
+153.42%
$5.54
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
IVP
+7.89%
$0.13
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
BTBT
+2.58%
$2.38
ADTX
+21.01%
$3.80
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CRCL
+10.03%
$79.93
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
CAN
+9.78%
$1.01
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
NWTN
-9.09%
$0.70
AG
+12.73%
$15.23
WBD
+0.50%
$24.00
APLD
+8.66%
$27.10
NGD
+6.50%
$8.35
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
NVDA
-0.38%
$176.31
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.67%
$17.27
ITUB
+1.82%
$7.80
AGNC
+0.47%
$10.49
INTC
-1.89%
$39.79
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
SNAP
-1.43%
$7.56
CRCG
+20.00%
$2.82
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
CRWV
-1.57%
$73.12
SHOT
-74.37%
$0.39
VIVK
-5.32%
$0.12
EXK
+15.19%
$9.93
ZAPP
-46.30%
$0.15
SNDK
+3.83%
$223.28
AVGO
+1.35%
$402.96
CMG
+1.43%
$34.52
MU
+2.70%
$236.48
ABVE
+14.06%
$3.00
NOK
0.00%
$6.08
PLTZ
-3.36%
$7.18
BMNU
-15.39%
$6.92
VSA
-7.30%
$0.11
MRVL
+1.91%
$89.40
SOUN
+1.94%
$12.05
SMCI
+3.10%
$33.85
IONZ
-10.02%
$4.13
IONQ
+5.11%
$49.30
BULL
+0.75%
$9.33
LAES
+6.93%
$4.47
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.